NCT00149292 Study of LY2140023 in Schizophrenia Comparing LY2140023, Olanzapine, and Placebo Status COMPLETED Phase PHASE2
NCT00148590 Memantine for the Prevention of Cognitive Dysfunction and Negative Symptoms in Patients With Acute Schizophrenia Status TERMINATED Phase PHASE3
NCT00148564 Energy Homeostasis Under Treatment With Atypical Antipsychotics Status COMPLETED Phase PHASE4
NCT00148447 The Efficacy of Escitalopram for Negative Symptoms in Schizophrenia Status COMPLETED Phase PHASE3
NCT00148083 Effects of Risperdal Consta on Ability to Benefit From Social Skills Training in Schizophrenia Status COMPLETED Phase PHASE3
NCT00145496 Efficacy and Safety of Asenapine Compared With Olanzapine in Patients With Persistent Negative Symptoms of Schizophrenia (A7501013)(COMPLETED)(P05771) Status COMPLETED Phase PHASE3
NCT00145444 Kahn Study; Investigation Of The Efficacy Of Ziprasidone Versus Olanzapine In The Management Of Recent-Onset Psychosis; A Flexible-Dose, Parallel Group, Double-Blind Study Status COMPLETED Phase PHASE3
NCT00144027 Patient-Centered Medication Adherence Intervention for Schizophrenia Status COMPLETED Phase NA
NCT00141479 To Evaluate the Impact of Treatment Interruption on Re-initiation of Bifeprunox Status COMPLETED Phase PHASE2
NCT00139919 Progressively Decreasing Titration Schedules of Bifeprunox in Subjects With Schizophrenia or Bipolar Disorder Status COMPLETED Phase PHASE2
NCT00139906 Twice Daily Titration Study of Bifeprunox in Subjects With Schizophrenia Status COMPLETED Phase PHASE2
NCT00139737 Extension Study: Evaluating the Safety of Oral Ziprasidone in the Treatment of Subjects With Schizophrenia Status COMPLETED Phase PHASE3
NCT00138775 Israel Multicenter D-Serine Study (IMSER) for the Treatment of Schizophrenia Status UNKNOWN Phase PHASE2
NCT00138021 Cognitive Remediation in Supported Employment at Human Service Center (HSC) Status UNKNOWN Phase NA
NCT00137280 Implementing Effective, Collaborative Care for Schizophrenia (EQUIP-2) Status COMPLETED Phase NA
NCT00137267 A Brief Community Linkage Intervention for Dually Diagnosed Individuals Status COMPLETED Phase NA